Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
Szilárd Kiss,1 Ying Liu,2 Joseph Brown,3 Nancy M Holekamp,4,5 Arghavan Almony,6 Joanna Campbell,2 Jonathan W Kowalski2 1Weill Cornell Medical College, New York, NY; 2Allergan, Inc., Irvine, CA; 3IMS Health, Woodland Hills, CA; 4Pepose Vision Institute, Chesterfield, MO; 5Washington Univ...
Guardado en:
Autores principales: | Kiss S, Liu Y, Brown J, Holekamp NM, Almony A, Campbell J, Kowalski JW |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62e4a2bd7544478297994e9de3b98974 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019) -
Treatment of macular edema due to retinal vein occlusions
por: Channa R, et al.
Publicado: (2011) -
Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema.
por: Bo-Een Hwang, et al.
Publicado: (2021) -
Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema
por: Bo-Een Hwang, et al.
Publicado: (2021) -
Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
por: Fujikawa M, et al.
Publicado: (2013)